EMV — EMvision Medical Devices Cashflow Statement
0.000.00%
Last trade - 00:00- AU$149.66m
- AU$135.96m
- AU$8.85m
Annual cashflow statement for EMvision Medical Devices, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | R2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.01 | 2.62 | 2.93 | 2.7 | 4.27 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.78 | 0.834 | -5.99 | -7.84 | -6.25 |
| Capital Expenditures | -0.191 | -0.187 | -0.302 | -0.05 | -0.124 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.191 | -0.187 | -0.302 | -0.05 | -0.124 |
| Financing Cash Flow Items | — | -0.075 | -0.002 | 0 | 0.074 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.08 | 2.45 | 15 | -0.258 | 13 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.89 | 3.1 | 8.71 | -8.14 | 6.65 |